Ana Armada
Overview
Explore the profile of Ana Armada including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
89
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Andrade M, Neves J, Bento M, Marques J, Seabra S, Silveira H, et al.
Antibiotics (Basel)
. 2025 Feb;
14(2).
PMID: 40001426
Antimicrobial-resistant is a growing threat to human health for which alternative therapeutic options are needed. In this study, we aimed to evaluate the efficacy of amlodipine (AML) and imipramine (IMI)...
2.
Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Infection
Valerio-Bolas A, Meunier M, Rodrigues A, Palma-Marques J, Ferreira R, Cardoso I, et al.
J Immunol Res
. 2025 Feb;
2025:3176927.
PMID: 39963187
Leishmaniasis is a group of parasitic diseases whose etiological agent is the protozoa . These diseases afflict impoverished populations in tropical and subtropical regions and affect wild and domestic animals....
3.
Valerio-Bolas A, Meunier M, Palma-Marques J, Rodrigues A, Santos A, Nunes T, et al.
Cells
. 2024 Mar;
13(5.
PMID: 38474410
Dendritic cells (DCs) capture pathogens and process antigens, playing a crucial role in activating naïve T cells, bridging the gap between innate and acquired immunity. However, little is known about...
4.
Armada A, Gomes B, Viveiros M, Rueff J, Rodrigues A
Cancer Drug Resist
. 2022 May;
2(3):897-911.
PMID: 35582584
ABCB1 is a major player in cancer drug resistance. The purpose of this study was to functionally assess the regulation of ABCB1 activity in a doxorubicin-resistant breast cancer cell line...
5.
Mendes A, Armada A, Cabral L, Amado P, Campino L, Cristiano M, et al.
Pharmaceuticals (Basel)
. 2022 Apr;
15(4).
PMID: 35455443
Leishmaniasis remains one of the ten Neglected Tropical Diseases with significant morbidity and mortality in humans. Current treatment of visceral leishmaniasis is difficult due to a lack of effective, non-toxic,...
6.
Gomes B, Honrado M, Armada A, Viveiros M, Rueff J, Rodrigues A
Int J Mol Sci
. 2020 Apr;
21(8).
PMID: 32340269
Cancer drug resistance (CDR) is a major problem in therapeutic failure. Over 90% of patients with metastatic cancer present CDR. Several mechanisms underlie CDR, including the increased expression of efflux...
7.
Armada A, Martins C, Spengler G, Molnar J, Amaral L, Rodrigues A, et al.
Methods Mol Biol
. 2016 Feb;
1395:87-103.
PMID: 26910071
The cell membrane P-glycoprotein (P-gp; MDR1, ABCB1) is an energy-dependent efflux pump that belongs to the ATP-binding cassette (ABC) family of transporters, and has been associated with drug resistance in...
8.
Pinto-Almeida A, Mendes T, Armada A, Belo S, Carrilho E, Viveiros M, et al.
PLoS One
. 2015 Oct;
10(10):e0140147.
PMID: 26445012
Background: Schistosomiasis is a neglected disease caused by a trematode of the genus Schistosoma that is second only to malaria in public health significance in Africa, South America, and Asia....
9.
Rabna P, Ramos J, Ponce G, Sanca L, Mane M, Armada A, et al.
PLoS One
. 2015 May;
10(5):e0127536.
PMID: 26017968
Background: This study aimed to evaluate the usefulness of the Xpert MTB/RIF assay for the rapid direct detection of M. tuberculosis complex (MTBC) strains and rifampicin resistance associated mutations in...
10.
Armada A, Gazarini M, Goncalves L, Antunes S, Custodio A, Rodrigues A, et al.
Exp Parasitol
. 2013 Jul;
135(1):166-74.
PMID: 23830988
Malaria cysteine proteases have been shown to be immunogenic and are being exploited as serodiagnostic markers, drug and vaccine targets. Several Plasmodium spp. cysteine proteases have been described and the...